SCHEMBL11974602

SCHEMBL11974602

CCCCCCc1ccc(-c2ccc(C)o2)o1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGS1 P23219 2/20 0.54
▸ PTGS2 P35354 2/20 0.54
▸ ALOX5 P09917 1/20 0.54
▸ EPHX2 P34913 1/20 0.43
▸ CHRM2 P08172 4/20 0.42
▸ CHRM5 P08912 3/20 0.42
▸ CHRM1 P11229 3/20 0.42
▸ CHRM3 P20309 3/20 0.42
▸ CHRM4 P08173 2/20 0.42
▸ POLB P06746 1/20 0.40
▸ MAPT P10636 2/20 0.39
▸ MEN1 O00255 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ ESR1 P03372 2/20 0.35
▸ ADRA2A P08913 2/20 0.35
▸ ADORA3 P0DMS8 2/20 0.35
▸ TACR2 P21452 2/20 0.35
▸ SLC6A2 P23975 2/20 0.35
▸ SLC6A4 P31645 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11130827 0.89 POLB (0.48) PTGS1PTGS2ALOX5EPHX2CHRM2
SCHEMBL18016713 0.89 POLB (0.48) PTGS1PTGS2ALOX5EPHX2CHRM2
SCHEMBL11907189 0.89 PTGS1 (0.59) PTGS1PTGS2ALOX5EPHX2CHRM2
SCHEMBL10343356 0.87 POLB (0.50) PTGS1PTGS2ALOX5EPHX2CHRM2
SCHEMBL8143743 0.81 POLB (0.52) ALOX5EPHX2CHRM2CHRM5CHRM1
SCHEMBL8921829 0.80 EPHX2 (0.57) PTGS1PTGS2ALOX5EPHX2CHRM2
SCHEMBL10878735 0.80 EPHX2 (0.57) PTGS1PTGS2ALOX5EPHX2CHRM2
SCHEMBL30889345 0.80 EPHX2 (0.57) PTGS1PTGS2ALOX5EPHX2CHRM2
SCHEMBL3924849 0.80 EPHX2 (0.57) PTGS1PTGS2ALOX5EPHX2CHRM2
SCHEMBL16753020 0.80 EPHX2 (0.57) PTGS1PTGS2ALOX5EPHX2CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8921582-B2 Oligo- and polyfurans, preparation and uses thereof YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2014-12-30 — — US disclosed
US-20140179934-A1 OLIGO- AND POLYFURANS, PREPARATION AND USES THEREOF YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2014-06-26 — — US disclosed
US-8759550-B2 Oligo- and polyfurans, preparation and uses thereof YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2014-06-24 — — US disclosed
US-20120209013-A1 OLIGO- AND POLYFURANS, PREPARATION AND USES THEREOF YEDA RESEARCH AND DEVELOPMENT CO.LTD (IL) 2012-08-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140179934-A1 OLIGO- AND POLYFURANS, PREPARATION AND USES THEREOF PUF60, POLI, DHFR PTGS1 2129/4885PTGS2 2419/4885ALOX5 432/4885
US-20120209013-A1 OLIGO- AND POLYFURANS, PREPARATION AND USES THEREOF PUF60, POLI, DHFR PTGS1 2129/4885PTGS2 2419/4885ALOX5 432/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback